Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients

出版年份 2015 全文链接

标题

作者

关键词

Lung adenocarcinoma, Epidermal growth factor receptor, Mutation, Gene amplification, Tyrosine kinase inhibitor, Tumor heterogeneity

出版物

LUNG CANCER

Volume 89, Issue 3, Pages 337-342

出版商

Elsevier BV

发表日期

2015-06-19

DOI

10.1016/j.lungcan.2015.06.008

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started